These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37568630)

  • 1. The Redox-Active Manganese(III) Porphyrin, MnTnBuOE-2-PyP
    Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Guedes de Pinho P; Fernandes AS; Oliveira NG
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Profiling Reveals Immune-Based Mechanisms Underlying Tumor Radiosensitization by a Novel Mn Porphyrin Clinical Candidate, MnTnBuOE-2-PyP
    Noh SU; Lim J; Shin SW; Kim Y; Park WY; Batinic-Haberle I; Choi C; Park W
    Antioxidants (Basel); 2024 Apr; 13(4):. PubMed ID: 38671924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-Active Mn Porphyrin-based Potent SOD Mimic, MnTnBuOE-2-PyP(5+), Enhances Carbenoxolone-Mediated TRAIL-Induced Apoptosis in Glioblastoma Multiforme.
    Yulyana Y; Tovmasyan A; Ho IA; Sia KC; Newman JP; Ng WH; Guo CM; Hui KM; Batinic-Haberle I; Lam PY
    Stem Cell Rev Rep; 2016 Feb; 12(1):140-55. PubMed ID: 26454429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the APE1 Redox Function Inhibitor E3330 in Non-small Cell Lung Cancer Cells Exposed to Cisplatin: Increased Cytotoxicity and Impairment of Cell Migration and Invasion.
    Manguinhas R; Fernandes AS; Costa JG; Saraiva N; Camões SP; Gil N; Rosell R; Castro M; Miranda JP; Oliveira NG
    Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32599967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MnTnHex-2-PyP
    Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Amaro F; Pinto J; Fernandes AS; Guedes de Pinho P; Oliveira NG
    Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese Porphyrin Promotes Post Cardiac Arrest Recovery in Mice and Rats.
    Wang P; Li Y; Yan B; Yang Z; Li L; Cao Z; Li X; Batinic-Haberle I; Spasojevic I; Warner DS; Sheng H
    Biology (Basel); 2022 Jun; 11(7):. PubMed ID: 36101338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for a novel manganese porphyrin compound as adjuvant canine lymphoma therapy.
    Boss MK; Dewhirst MW; Sampaio RS; Bennett A; Tovmasyan A; Berman KG; Beaven AW; Rizzieri DA; Batinic-Haberle I; Hauck ML; Spasojevic I
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):421-431. PubMed ID: 28685347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurobehavioral radiation mitigation to standard brain cancer therapy regimens by Mn(III) n-butoxyethylpyridylporphyrin-based redox modifier.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Boico A; Birer SR; Roy Choudhury K; Herndon J; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Batinic-Haberle I; Dewhirst MW
    Environ Mol Mutagen; 2016 Jun; 57(5):372-81. PubMed ID: 27224425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the Continuum of Radiation-Induced Normal Tissue Injury by a Redox-Active Mn Porphyrin.
    Birer SR; Lee CT; Choudhury KR; Young KH; Spasojevic I; Batinic-Haberle I; Crapo JD; Dewhirst MW; Ashcraft KA
    Radiat Res; 2017 Jul; 188(1):94-104. PubMed ID: 28517962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Effects of Redox Modifier MnTnBuOE-2-PyP 5+ on Cognition and Hippocampal Physiology Following Doxorubicin, Cyclophosphamide, and Paclitaxel Treatment.
    McElroy T; Brown T; Kiffer F; Wang J; Byrum SD; Oberley-Deegan RE; Allen AR
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioprotection of the brain white matter by Mn(III) n-Butoxyethylpyridylporphyrin-based superoxide dismutase mimic MnTnBuOE-2-PyP5+.
    Weitzel DH; Tovmasyan A; Ashcraft KA; Rajic Z; Weitner T; Liu C; Li W; Buckley AF; Prasad MR; Young KH; Rodriguiz RM; Wetsel WC; Peters KB; Spasojevic I; Herndon JE; Batinic-Haberle I; Dewhirst MW
    Mol Cancer Ther; 2015 Jan; 14(1):70-9. PubMed ID: 25319393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS bioavailability and radiation protection of normal hippocampal neurogenesis by a lipophilic Mn porphyrin-based superoxide dismutase mimic, MnTnBuOE-2-PyP
    Leu D; Spasojevic I; Nguyen H; Deng B; Tovmasyan A; Weitner T; Sampaio RS; Batinic-Haberle I; Huang TT
    Redox Biol; 2017 Aug; 12():864-871. PubMed ID: 28454069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase mimic, MnTE-2-PyP(5+) ameliorates acute and chronic proctitis following focal proton irradiation of the rat rectum.
    Archambeau JO; Tovmasyan A; Pearlstein RD; Crapo JD; Batinic-Haberle I
    Redox Biol; 2013; 1(1):599-607. PubMed ID: 24363995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR78 Regulates Autophagy and Drug Resistance in Non-small Cell Lung Cancer.
    Liao X; Cai R; Li G; Chen F
    Altern Ther Health Med; 2023 Jan; 29(1):130-136. PubMed ID: 35986740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the redox-active MnTnHex-2-PyP
    Soares RB; Pinto J; Amaro F; Manguinhas R; Gil N; Rosell R; Batinic-Haberle I; Fernandes AS; Oliveira NG; Guedes de Pinho P
    Biochem Pharmacol; 2024 Sep; 227():116424. PubMed ID: 39004232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Manganese-Porphyrin Superoxide Dismutase-Mimetic Widens the Therapeutic Margin in a Preclinical Head and Neck Cancer Model.
    Ashcraft KA; Boss MK; Tovmasyan A; Roy Choudhury K; Fontanella AN; Young KH; Palmer GM; Birer SR; Landon CD; Park W; Das SK; Weitner T; Sheng H; Warner DS; Brizel DM; Spasojevic I; Batinic-Haberle I; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):892-900. PubMed ID: 26530759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP
    Chaiswing L; Yarana C; St Clair W; Tovmasyan A; Batinic-Haberle I; Spasojevic I; St Clair D
    Oxid Med Cell Longev; 2022; 2022():9664636. PubMed ID: 35898616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges encountered during development of Mn porphyrin-based, potent redox-active drug and superoxide dismutase mimic, MnTnBuOE-2-PyP
    Rajic Z; Tovmasyan A; de Santana OL; Peixoto IN; Spasojevic I; do Monte SA; Ventura E; Rebouças JS; Batinic-Haberle I
    J Inorg Biochem; 2017 Apr; 169():50-60. PubMed ID: 28131001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.
    Baghbani E; Noorolyai S; Rahmani S; Shanehbandi D; Shadbad MA; Aghebati-Maleki L; Mokhtarzadeh A; Brunetti O; Fasano R; Silvestris N; Baradaran B
    Biomed Pharmacother; 2022 Jan; 145():112370. PubMed ID: 34862113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MnTnBuOE-2-PyP protects normal colorectal fibroblasts from radiation damage and simultaneously enhances radio/chemotherapeutic killing of colorectal cancer cells.
    Kosmacek EA; Chatterjee A; Tong Q; Lin C; Oberley-Deegan RE
    Oncotarget; 2016 Jun; 7(23):34532-45. PubMed ID: 27119354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.